C. cochlearium 2316 Ameliorates High-Fat Diet-Induced Obesity and Metabolic Syndrome Risk Factors via Enhanced Energy Expenditure and Glucose Homeostasis
Nutrients · 2025
DOI: 10.3390/nu17243848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Wenjun Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Science, Wayne State University, Detroit, MI 48202, USA. Hauptthemen laut MEDLINE: Diet, High-Fat, Obesity, Energy Metabolism, Metabolic Syndrome. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study investigated the potential beneficial effects of a probiotic candidate, Clostridium cochlearium 2316, in modulating physiological and metabolic markers in mice with high-fat diet-induced obesity (DIO).
Methods
C57BL/6 DIO mice were assigned to three groups (ad libitum): standard low-fat control (LF, 10% fat), high-fat diet (HF, 60% fat), and high-fat diet supplemented with approximately one billion CFU/day of CC2316 via daily oral gavage for 16 weeks.
Results
After 16 weeks, the CC group exhibited 17.3% lower body weight gain (p < 0.001) and significant fat mass decrease (p < 0.0001) compared to HF mice. Serum biochemistry showed that CC2316 supplementation resulted in a 27.7% reduction in fasting blood glucose (p < 0.05), a 58.4% reduction in fasting insulin (p < 0.01), and an 89.4% improvement in HOMA-IR score (p < 0.05). Furthermore, serum total cholesterol level decreased dramatically by 40.2% in the CC group (p < 0.001). Despite a higher caloric absorption rate (p < 0.001), CC mice demonstrated a significant beneficial shift in energy expenditure, characterized by an increased basal metabolic rate (p < 0.05), higher energy expenditure (p < 0.05), and an elevated respiratory quotient (RER) (p < 0.05), alongside increased physical activity (p < 0.05).
Conclusions
This investigation strongly suggests that CC2316 supplementation mitigates the adverse effects of HFD-induced obesity by modulating whole-body energy metabolism, positioning it as a potential aid to lower risk factors associated with metabolic syndrome. The precise mechanisms linking the gut microbiome to altered energy substrate utilization are discussed and suggested for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Science, Wayne State University, Detroit, MI 48202, USA.
- Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA 16802, USA.
ORCID-Profile: Qing Ai, Md Abdul Alim, Zerui Liao
Zitieren
APA
Zhu, W., Edirisuriya, P., Ai, Q., Yang, F., Tang, J., Nie, K., Ji, X., Soltanieh, S., Musarrat, M., Alim, M. A., Liao, Z., & Zhou, K. (2025). C. cochlearium 2316 Ameliorates High-Fat Diet-Induced Obesity and Metabolic Syndrome Risk Factors via Enhanced Energy Expenditure and Glucose Homeostasis. Nutrients. https://doi.org/10.3390/nu17243848
Vancouver
Zhu W, Edirisuriya P, Ai Q, Yang F, Tang J, Nie K, et al. C. cochlearium 2316 Ameliorates High-Fat Diet-Induced Obesity and Metabolic Syndrome Risk Factors via Enhanced Energy Expenditure and Glucose Homeostasis. Nutrients. 2025. doi:10.3390/nu17243848
BibTeX
@article{Zhu2025,
author = {Zhu, Wenjun and Edirisuriya, Paba and Ai, Qing and Yang, Fei and Tang, Jiangqi and Nie, Kai and Ji, Xiangming and Soltanieh, Samira and Musarrat, Maesha and Alim, Md Abdul and Liao, Zerui and Zhou, Kequan},
title = {C. cochlearium 2316 Ameliorates High-Fat Diet-Induced Obesity and Metabolic Syndrome Risk Factors via Enhanced Energy Expenditure and Glucose Homeostasis},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17243848}
}
EUVIMED